Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of microRNAs in skin development was shown in a keratinocyte-specific Dicer knockout mouse model. Considering that two main characteristics of psoriasis are keratinocytes hyperproliferation and abnormal skin differentiation, we hypothesized that aberrant microRNA expression contributes to the psoriatic phenotype. Here, we describe the differential expression of miRNAs in psoriatic involved and uninvolved skin as compared to normal skin, revealing an additional aspect of this complex disorder., miR-99a expression increases over time. Finally, we found that IGF1 increases the expression of miR-99a.We identified several microRNAs that are expressed differentia...
Psoriasis is a chronic inflammatory skin disease that is mediated by complex crosstalk between immun...
miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of ski...
Psoriasis is a common and chronic autoimmune skin disease which affects 2 to 3% of the world populat...
Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of microRNAs in...
BACKGROUND: Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of ...
MicroRNAs are a recently discovered class of posttranscriptional regulators of gene expression with ...
MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as central regulators of gene express...
Psoriasis is a chronic, autoimmune, and complex genetic disorder that affects 23% of the European po...
MicroRNAs (miRNAs) are small non-coding RNA molecules, which function in RNA silencing and post-tran...
Psoriasis is a chronic inflammatory skin disease. Although miRNAs are reported to be associated with...
Background. Psoriasis is an immune-mediated inflammatory chronic skin disease characterized by chron...
MicroRNAs are short non-coding RNAs that regulate gene expression. Previously, in a genome-wide scre...
Psoriasis is a chronic, inflammatory skin disease characterized by hyperproliferation and altered di...
Psoriasis is one of the most common chronic inflammatory skin diseases. It is a life long suffering ...
International audiencePsoriasis is a chronic inflammatory skin disease that is mediated by complex c...
Psoriasis is a chronic inflammatory skin disease that is mediated by complex crosstalk between immun...
miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of ski...
Psoriasis is a common and chronic autoimmune skin disease which affects 2 to 3% of the world populat...
Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of microRNAs in...
BACKGROUND: Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of ...
MicroRNAs are a recently discovered class of posttranscriptional regulators of gene expression with ...
MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as central regulators of gene express...
Psoriasis is a chronic, autoimmune, and complex genetic disorder that affects 23% of the European po...
MicroRNAs (miRNAs) are small non-coding RNA molecules, which function in RNA silencing and post-tran...
Psoriasis is a chronic inflammatory skin disease. Although miRNAs are reported to be associated with...
Background. Psoriasis is an immune-mediated inflammatory chronic skin disease characterized by chron...
MicroRNAs are short non-coding RNAs that regulate gene expression. Previously, in a genome-wide scre...
Psoriasis is a chronic, inflammatory skin disease characterized by hyperproliferation and altered di...
Psoriasis is one of the most common chronic inflammatory skin diseases. It is a life long suffering ...
International audiencePsoriasis is a chronic inflammatory skin disease that is mediated by complex c...
Psoriasis is a chronic inflammatory skin disease that is mediated by complex crosstalk between immun...
miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of ski...
Psoriasis is a common and chronic autoimmune skin disease which affects 2 to 3% of the world populat...